I N Guha

Summary

Publications

  1. pmc Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease
    I N Guha
    Liver Group, Division of Infection, Inflammation, and Repair, University of Southampton, Mail point 811, Level D, South Academic Block, Southampton General Hospital, Southampton S016 6YD, UK
    Gut 55:1650-60. 2006
  2. ncbi request reprint Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers
    Indra Neil Guha
    Liver Group, University of Southampton, Southampton, UK
    Hepatology 47:455-60. 2008
  3. doi request reprint Noninvasive assessment of liver fibrosis: serum markers, imaging, and other modalities
    I N Guha
    Liver Group, University of Southampton, Southampton, UK
    Clin Liver Dis 12:883-900, x. 2008
  4. doi request reprint Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C
    J Parkes
    Public Health Sciences and Medical Statistics, University of Southampton, UK
    J Viral Hepat 18:23-31. 2011
  5. ncbi request reprint Performance of serum marker panels for liver fibrosis in chronic hepatitis C
    Julie Parkes
    Public Health Sciences and Medical Statistics, University of Southampton, Level C South Academic Block, Southampton SO17 1BJ, UK
    J Hepatol 44:462-74. 2006
  6. ncbi request reprint Resolving fibrosis in the diseased liver: translating the scientific promise to the clinic
    Ajay K Muddu
    Liver Group, Division of Infection, Inflammation and Repair, University of Southampton, Southampton SO16 6YD, United Kingdom
    Int J Biochem Cell Biol 39:695-714. 2007

Collaborators

Detail Information

Publications6

  1. pmc Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease
    I N Guha
    Liver Group, Division of Infection, Inflammation, and Repair, University of Southampton, Mail point 811, Level D, South Academic Block, Southampton General Hospital, Southampton S016 6YD, UK
    Gut 55:1650-60. 2006
    ..We will discuss the biological plausibility, limitations, potential uses, and emerging diagnostic techniques of non-invasive markers in this rapidly expanding field...
  2. ncbi request reprint Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers
    Indra Neil Guha
    Liver Group, University of Southampton, Southampton, UK
    Hepatology 47:455-60. 2008
    ..The addition of established simple markers augments the diagnostic performance across different stages of fibrosis, which will potentially allow superior stratification of patients with NAFLD for emerging therapeutic strategies...
  3. doi request reprint Noninvasive assessment of liver fibrosis: serum markers, imaging, and other modalities
    I N Guha
    Liver Group, University of Southampton, Southampton, UK
    Clin Liver Dis 12:883-900, x. 2008
    ..This article outlines the various noninvasive markers, including blood tests, imaging, and novel technologies. It examines the principles behind their development, their diagnostic accuracy, and their evolution...
  4. doi request reprint Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C
    J Parkes
    Public Health Sciences and Medical Statistics, University of Southampton, UK
    J Viral Hepat 18:23-31. 2011
    ..Issues of spectrum effect in diagnostic test evaluations are discussed. In chronic hepatitis C a simplified ELF test can detect severe liver fibrosis with good accuracy...
  5. ncbi request reprint Performance of serum marker panels for liver fibrosis in chronic hepatitis C
    Julie Parkes
    Public Health Sciences and Medical Statistics, University of Southampton, Level C South Academic Block, Southampton SO17 1BJ, UK
    J Hepatol 44:462-74. 2006
    ..Chronic hepatitis C (CHC) is characterised by hepatic fibrosis, used as a proxy measure of prognosis. Liver biopsy is a flawed reference standard and serum markers of fibrosis offer an attractive alternative...
  6. ncbi request reprint Resolving fibrosis in the diseased liver: translating the scientific promise to the clinic
    Ajay K Muddu
    Liver Group, Division of Infection, Inflammation and Repair, University of Southampton, Southampton SO16 6YD, United Kingdom
    Int J Biochem Cell Biol 39:695-714. 2007
    ..In addition, we review the latest developments in the search for minimal invasive diagnostic tests for fibrosis that will be essential for determining the efficacy of anti-fibrotic drugs...